Havas Health named Anna Maria Marra as CEO of Europe on Tuesday morning, a role in which she will lead and oversee all ...

Pfizer hired Marra all the way back in 2002, at which time the new Havas Health exec had spent a few years working at Merck ...

Her career spans more than 26 years across four continents, during which she has held key leadership roles in marketing, ...

JP Morgan has recently reduced Organon & Co (OGN) stock to Underweight rating, as announced on September 6, 2024, according to Finviz. Earlier, on November 3, 2023, Goldman had reduced the stock from ...

Daewoong Pharmaceutical announced on October 31 that it has signed a joint sales agreement with Celltrion Pharm to market CT-P41 ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower ...

On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab). In ...

Last night Ward6 picked up another trophy at this year’s PRIME Awards. The agency won Launch of the Year for The PRIME Awards ...

Organon's OGN short percent of float has risen 28.4% since its last report. The company recently reported that it has 12.53 ...

They made the remarks as the international exchange platform, in its seventh edition this year, has attracted many leading ...

International Assets Investment Management LLC increased its holdings in Organon & Co. (NYSE:OGN – Free Report) by 1,851.8% in the third quarter, HoldingsChannel.com reports. The institutional ...